INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 241 filers reported holding INTRA CELLULAR THERAPIES INC in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,559,523 | +52.5% | 29,939 | +85.4% | 0.00% | +50.0% |
| Q2 2023 | $1,022,365 | +40.4% | 16,146 | +20.1% | 0.00% | 0.0% |
| Q1 2023 | $728,263 | -27.5% | 13,449 | -29.2% | 0.00% | 0.0% |
| Q4 2022 | $1,005,004 | +6.1% | 18,991 | -6.7% | 0.00% | 0.0% |
| Q3 2022 | $947,000 | -28.0% | 20,345 | -11.7% | 0.00% | -33.3% |
| Q2 2022 | $1,316,000 | +119.0% | 23,047 | +134.6% | 0.00% | +200.0% |
| Q1 2022 | $601,000 | +34.8% | 9,825 | +15.3% | 0.00% | 0.0% |
| Q4 2021 | $446,000 | +40.3% | 8,522 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $318,000 | -8.6% | 8,522 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $348,000 | -44.2% | 8,522 | -53.7% | 0.00% | 0.0% |
| Q1 2021 | $624,000 | -40.2% | 18,394 | -44.0% | 0.00% | -50.0% |
| Q4 2020 | $1,044,000 | -21.2% | 32,835 | -36.4% | 0.00% | 0.0% |
| Q3 2020 | $1,325,000 | -16.7% | 51,648 | -16.6% | 0.00% | -33.3% |
| Q2 2020 | $1,590,000 | +68.8% | 61,930 | +1.0% | 0.00% | +50.0% |
| Q1 2020 | $942,000 | +316.8% | 61,314 | +209.1% | 0.00% | – |
| Q4 2018 | $226,000 | -58.5% | 19,837 | -21.0% | 0.00% | -100.0% |
| Q3 2018 | $545,000 | +23.6% | 25,112 | +0.6% | 0.00% | – |
| Q2 2018 | $441,000 | +53.7% | 24,966 | +32.3% | 0.00% | – |
| Q3 2016 | $287,000 | -56.9% | 18,864 | +9.9% | 0.00% | -100.0% |
| Q2 2016 | $666,000 | +15.0% | 17,162 | -17.5% | 0.00% | 0.0% |
| Q1 2016 | $579,000 | -70.8% | 20,814 | -43.5% | 0.00% | -66.7% |
| Q4 2015 | $1,982,000 | +16.7% | 36,856 | -13.1% | 0.00% | 0.0% |
| Q3 2015 | $1,699,000 | +65.6% | 42,428 | +32.2% | 0.00% | +50.0% |
| Q2 2015 | $1,026,000 | +294.6% | 32,101 | +194.5% | 0.00% | +100.0% |
| Q1 2015 | $260,000 | – | 10,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $42,833,000 | 8.57% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 308,819 | $18,897,000 | 7.82% |
| Vahanian & Associates Financial Planning Inc. | 45,533 | $2,786,000 | 6.44% |
| DCF Advisers, LLC | 238,500 | $14,594,000 | 6.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 50,956 | $20,930,000 | 4.72% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,531,923 | $93,738,000 | 2.86% |
| Nicholas Investment Partners, LP | 562,373 | $34,412,000 | 2.45% |
| Bellevue Group AG | 3,429,619 | $209,859,000 | 2.44% |
| WASATCH ADVISORS LP | 7,477,868 | $457,571,000 | 2.25% |
| Quantum Private Wealth, LLC | 73,772 | $4,514,000 | 1.95% |